| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
| mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
7e-06 |
| mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0002 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |